Publication dates

Leukemia Industry, September 2014 Market Reports from Top Publishers

You might be interested in: cancer, nucleic acid testing, flow cytometry, more »


 
1-10 of about 200 reports for Leukemia

Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2014 Update

Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Releases the only comprehensive genomic test to diagnose & stratify the most common form of leukemia (cll) 31jun 03, 2014: cancer genetics, inc. Partners with leading southwest gynecological pathology ...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

... For the indicated disease.Scope- the report provides a snapshot of the global therapeutic landscape of acute lymphocytic leukemia (all, acute lymphoblastic leukemia)- the report reviews key ...

Seegene, Inc. (096530) - Product Pipeline Analysis, 2014 Update

Seegene, Inc. (096530) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • August 2014
  • by Global Data

... Product description 55seeplex influenza a/b onestep typing - product status 56seeplex influenza a/b onestep typing - product description 56seeplex leukemia aml1/eto ace assay - product status ...

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Or business research. - Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Deals by valuemost active prostate cancer partnering companies11. leukemialeukemia partnering in numberstop leukemia partnering deals by valuemost active leukemia partnering companies ...

Leukemia Partnering 2009-2014

Leukemia Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Links to online copies of actual leukemia deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide ...

Acute and Chronic Myelogenous Leukemia Partnering 2009-2014

Acute and Chronic Myelogenous Leukemia Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... And chronic myelogenous leukemia partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends ...

 Acute Promyelocytic Leukemia-Pipeline Insights, 2014

Acute Promyelocytic Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under acute promyelocytic leukemia. This report provides information ...

 B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2014

B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... About pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under b-cell chronic lymphocytic leukemia. This report ...

 B-Cell Leukemia-Pipeline Insights, 2014

B-Cell Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under b-cell leukemia. This report provides information on the therapeutic development based ...

About 2 000 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Agrochemical Industry in Brazil

  • In Utero Pesticide Exposure and Leukemia in Brazilian Children <...
  • January 2012
    7 pages
  • Leukemia  

    Cancer  

  • Brazil  

    South America  

View report >

Pathology Description

January 2012

10 Companies for Leukemia

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Celgene Corp.

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.